DrugDevCovid19

Tracking the relevant researches of CADD drug development against COVID-19

Rubitecan

ID MW HBD HBA
472335  393.316
RB NOA Rings logP
2951.57

Function

DrugBank ID:

DB06159


Description:

Not Available [DrugBank]

Targets:

DNA topoisomerase 1 (Humans) [DrugBank]

Pharmacodynamics:

Not Available [DrugBank]

Structures

SMILES:

CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c([N+](=O)[O-])cccc3nc2-1

2D structures:  

3D structures:  

Docking in target protein

Receptor: TMPRSS2

Docking Site: Catalytic pocket

Ligand: Rubitecan

Vina score: -7.6

Off-target analysis based on ligand similarity (Homo sapiens)

Step 1 - Target prediction for Rubitecan: SwissTargetPrediction

Tips: Click on the link to jump to the 'SwissTargetPrediction' webserver. Select the species of 'Homo sapiens', and then paste the SMILES of Rubitecan in the SMILES input box.

Step 2 - Blind docking for Rubitecan: CB-Dock

Tips: Click on the link to jump to the 'CB-Dock' webserver. Upload the structure file of target predicted by 'SwissTargetPrediction' and the 2D/3D structure file of Rubitecan to perform blind docking.